Member Info for HarChris

I follow Largo's share price closely and have noticed it very rarely makes a move north when the Nasdaq is down.
Today the nasdaq has seen one of its biggest losses in a year whilst Largo is surging into the COB, up 9% - very, very good sign for us.

Afraid not. Argo, being listed on the nasdaq technically trades beyond London hours - it's currently tanking in the US and therefore will open below the price you bought it yesterday. + of course the 0.5% you paid.

I don't see the price of V rolling back from here, absolutely not. Numerous factors were coming together to create a supply squeeze even before Russia invaded, all it did was accelerate it. Even if there is a ceasefire sanctions won't be lifted and Russia will remain a pariah state for years to come.

It's really a case of where the rise in vanadium stops, $55/kg, $65/kg or way higher. The lower end would be better long term for Bushveld and the higher end will almost certainly cause a share price spike akin to 2018 .

That's true digby. Also their market cap had dropped so low (sub £10m) that any potential good news could see a significant move so speculators will be there trying to catch a bounce.

I won't mention your name again if you stop with your stupid finger in the air price predictions that change from one day to the next.

Wilson I think you misunderstood what I was saying. Lewis bought back in a few weeks ago and then sold today because of the 'silence'. There has certainly been no promise of an update within that timeframe.

Your logic is totally flawed Lewis and proves that you don't think for yourself and instead get caught up in the excitement of a rising share. There has never been any expectation of news here until April... this is when we have guaranteed news and a pivotal next step at that (detailed plans for what the future looks like under DA). And yet you sell out today, much closer to news because of the 'silence' as if the company has suddenly changed tact? And well below where you bought in weeks ago and once again, as you did last time, sold and started scaremongering.

I'm only picking on you for sharing all these buys and sells because in reality you don't know what you're doing and are trying to make yourself out to be some knowledgeable trader with insight.

It's important to see who is genuine or at least who has an attention span greater than a goldfish. Lewis shared that he bought back in after the first biosynex TR1 (190p?) and then kept topping up (I think in the 200s). Last week he was retweeting every novacyt ramp as well as posting this just a few days ago: https://twitter.com/lewis79654924/status/1499737692761899018

Today sold at 133p.

There’s a saying in the Bitcoin and crypto community that goes ‘it’s still early’ to convince new entrants to commit more funds before the masses cotton on…

In the case of VRFBs I think it genuinely applies.

Another big loss for you crystallised, this time at well below cash value. Hope it works out well for you!

I genuinely cannot believe that anyone places precedence on a 'head and shoulders pattern forming' on a chart over the very real fundamental reality that is taking place rapidly before our eyes brought on by war.

It truly beggar's belief.

Everything keeps getting deleted so I will say it again.

In times like this, EVERY company that is directly or indirectly negatively affected by the Russian invasion will see a sizeable hit to their share price... investors instead look for safe havens, businesses and commodities that directly benefit from what's going on right now, think gold, precious metals etc. Gains and losses are exaggerated at either end of the spectrum.

It's never pleasant to make money from war, invasion, loss, suffering even if those profits are made indirectly but that's the case with BMN right now, Russia is fast becoming a pariah state and with 17% of global V production this causes a squeeze on an already tight market.

With every 3% daily rise in V, Bushveld is making millions more and this investment becomes more and more derisked... and with the share price starting at such a low this had miles left to run before it even approaches fair value.

ValJu if you read my posts over the weekend there's no suggestion that the share price will react any time soon, that we will suddenly see the share price match the great prospects here. Not in the very near term certainly. But despite what's happened before, if you aren't disillusioned by it all (like you clearly are) you might be able to see that it's possible to buy this company below cash (for all the reasons I went through at the weekend) and in time will be bloody happy you did.

Sadly it will be the ones only just coming across novacyt now or having sold in the past and sitting on the sidelines, free from the disappointments of the last year and without the misfortune of sitting on huge losses that will make the most of the opportunity presenting itself.

Come on Valju, it isn't hard to understand. You've answered your own question. Evraz has seen the most enormous selloff in just a few days and now traders are taking speculative punts in order to try and catch a bounce. They'll be out tomorrow and it will crash again.

Biosynex were accumulating novacyt shares but what then seems to have happened is their own shares started crashing (as all have recently) and instead they switched to buying back their own shares (having commenced a buy back some time ago).

If every other share hadn't suddenly seen enormous falls investors and traders would be rushing to buy novacyt at below cash but instead they will be preoccupied with trying to recover their recent losses rather than moving their now depleted funds into a medium term safe haven cash cow.

It sucks being on even bigger paper losses but novacyt are totally unaffected materially by this invasion and the likely subsequent economic fallout. The sad truth is it will probably benefit them by making acquisition targets much cheaper and pushing some struggling competitors into bankruptcy.

I agree. At times novacyt was very overpriced and many got carried away, caught up in the hype (including me).

Recent history and price action is ugly but that doesn't mean they aren't grossly undervalued now, it just means it's going to be difficult and take time to convince the market - a silent period in amongst a market crash isn't likely to be prime time.

Because shares are far more liquid than housing assets many will try to jump out of one and into another in other to make a quick buck - this leads to a far larger disconnect between the price and what's generally considered 'fair value' in the short term.

If a terrorist attack takes place in your leafy suburban London neighbourhood I imagine, short term, buyers will try their luck and reduce the price they are willing to pay for your house. At that precise moment in time 'fair value' is the price buyers are willing to pay but most people would still recognise it's best to hold out on to that asset until normality returns.

Generally I look at 'fair value' at what price would a takeover bid be accepted at. This allows you to take into account many factors, including sentiment, not ONLY sentiment, which tends to control prices on AIM at extreme times.

If a bid came in for novacyt at £100m/ £1.40 a share it wouldn't be accepted, so no it's not 'fairly valued' but if some want to pass on their shares at that price that's up to them.

'7 November 2017 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces it has won, for the second consecutive year, the Ile-de-France award of the Deloitte Technology Fast 50 French programme, an initiative that rewards fast growing companies.'

Let's not forget that there must be thousands of companies out there with talented staff, great ideas, ambition, but all of that counts for little if you don't have the funds to bring those ideas to life. To a degree I also agree with PI100 that novacyt won the 'covid lottery' - the difference that £150m net profit can make to an innovative company previously lacking funds is not something to be trivialised.